Research Collaboration Index · 2026
Europe · Platinum standing
Strongest in Business, Management & Accounting, at #44 in the world.
The profile
By subject
World rank in each of the 26 subject indices; gold cards mark top-500 standings. Click through to any full subject ranking.
GRP Partnership Intelligence Platform
The peers you choose beside you across both GRP indices, the universities and companies your peers work with that you do not, live funding calls matched to your strengths and a brief ready for your executive. A partner service now onboarding founding partner universities: enquire, and the GRP team will confirm availability and pricing for your university.
Request first access for University of Sheffield →
Independence. The index is free, public and independent; no commercial relationship changes any position. The platform, a partner service arranged with each university, reads the published record and cannot move a position.
Featured academics
Independently verified: current affiliation, public profile and published contact confirmed from the open record.
Blakeley co-directed The Rendition Project, which produced the most comprehensive public analysis of the CIA rendition and secret detention programme. Now Vice President and Head of the Faculty of Social Sciences at Sheffield, she continues publishing on state violence, torture and accountability, including the ongoing Guantanamo detentions and military commission prosecutions.
Azzouz translates gene therapy from bench to clinic for motor neuron disease and other neurodegenerative conditions, developing viral vectors for gene replacement and gene silencing. He directs Sheffield's Gene Therapy Innovation and Manufacturing Centre, one of the few UK facilities able to produce clinical grade vectors for academic led trials.
Shaw founded the Sheffield Institute for Translational Neuroscience and directs the NIHR Biomedical Research Centre, building one of Europe's largest motor neuron disease research and care programmes. Her work on the genetic subtypes of ALS underpins stratified clinical trials of gene therapies and small molecules, including tofersen for SOD1 related disease.
Latest research news